As Sr. Director of Product Management, Jessica is responsible for the Advanced Therapy and Rare Disease and Gene Therapy portfolios. In this role, she has overall business management and strategic planning accountability of the portfolio and ensures her team is driving innovative program offerings in the Bleeding Disorders, Immune Disorders, Pulmonary Hypertension and Rare Therapeutic Resource Centers.

Jessica joined Express Scripts in 2001 in the Product Management organization and transitioned to Accredo in 2016. Prior to joining Express Scripts, Jessica worked at a boutique healthcare consulting firm focusing on business development, portfolio management and market research for pharmaceutical manufacturers. Jessica has a Bachelor of Science in Biology, with a Minor in Genetics from Duke University and Master of Business Administration from Washington University – St Louis.